B5387e98-figure-01 (B5387e98 Figure 01)
Redpharm Drug
Product Images NDC 67296-0769
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Redpharm Drug (NDC 67296-0769). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
B5387e98-figure-02 (B5387e98 Figure 02)
B5387e98-figure-03 (B5387e98 Figure 03)
This text appears to be a description of a pharmaceutical product. It mentions "Albuterol" and "Ipratropium" mixed in an inhalation solution, possibly used for the treatment of respiratory conditions such as asthma or chronic obstructive pulmonary disease.*
B5387e98-figure-04 (B5387e98 Figure 04)
This text provides information on adverse events occurring in different treatment groups and the highest percentage of those occurrences. The data includes the number of patients, percentage of patients with adverse events, and specific adverse events related to different body systems such as BODY AS AWHOLE, DIGESTIVE, MUSCULO-SKELETAL, RESPIRATORY, and UROGENITAL. Some of the adverse events mentioned are pain, pain chest, diarrhea, dyspepsia, nausea, cramps leg, bronchitis, lung disease, pharyngitis, pneumonia, and urinary tract infection. This information can be used for medical evaluation and monitoring of treatments.*
B5387e98-figure-05 (B5387e98 Figure 05)
B5387e98-figure-06 (B5387e98 Figure 06)
B5387e98-figure-07 (B5387e98 Figure 07)
B5387e98-figure-08 (B5387e98 Figure 08)
Figure 09 (B5387e98 Figure 09)
This is a description of a medication containing Ipratropium Bromide and Albuterol Sulfate for oral inhalation. Each vial contains 0.5 mg of Ipratropium Bromide and 3 mg of Albuterol Sulfate. It should be stored between 2°C and 25°C, protected from light, in the provided pouch until use. The vials should be used within one week of opening and discarded if the solution is not colorless. It is important to follow the prescribing information and consult a physician or pharmacist for further details. This medication is available as a 5 x 3 mL unit-dose vials.*
Figure 10 (B5387e98 Figure 10)
This text provides information about a medication with National Drug Code (NDC) 0467-0201-03 containing Ipratropium Bromide 0.5 mg and Albuterol Sulfate 3 mg for oral inhalation use. The text also mentions another NDC code 0487-0201-03 for the same medication. It is indicated for respiratory conditions.*
Figure 11 (B5387e98 Figure 11)
This is a prescription for an oral inhalation medication containing Ipratropium Bromide 0.5 mg and Albuterol Sulfate 3 mg. The medication is meant for oral inhalation only. The label also contains the product codes NDC 0487020150 and NDC 0487-020150. Please consult a healthcare professional before using this medication.*
Figure 12 (B5387e98 Figure 12)
This text provides detailed patient instructions for using Ipratropium Bromide and Albuterol Sulfate for oral inhalation. It includes steps on how to properly use the medication with a nebulizer for effective administration. The text also mentions storage conditions, dosage information, and emphasizes that the medication should only be used under the direction of a physician. Additionally, it includes contact information for customer service and manufacturer details.*
Figure 13 (B5387e98 Figure 13)
Figure 14 (B5387e98 Figure 14)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
